Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Main subject
Language
Document Type
Year range
1.
biorxiv; 2022.
Preprint in English | bioRxiv | ID: ppzbmed-10.1101.2022.08.19.504579

ABSTRACT

Latin America is one of the regions in which the COVID-19 pandemic has had a stronger impact, with more than 72 million reported infections and 1.6 million deaths until June 2022. Since this region is ecologically diverse and is affected by enormous social inequalities, efforts to identify genomic patterns of the circulating SARS-CoV-2 genotypes are necessary for the suitable management of the pandemic. To contribute to the genomic surveillance of the SARS-CoV-2 in Latin America, we extended the number of SARS-CoV-2 genomes available from the region by sequencing and analyzing the viral genome from COVID-19 patients from seven countries (Argentina, Brazil, Costa Rica, Colombia, Mexico, Bolivia and Peru). Subsequently, we analyzed the genomes circulating mainly during 2021 including records from GISAID database from Latin America. A total of 1534 genome sequences were generated from seven countries, demonstrating the laboratory and bioinformatics capabilities for genomic surveillance of pathogens that have been developed locally. For Latin America, patterns regarding several variants associated with multiple re-introductions, a relatively low percentage of sequenced samples, as well as an increment in the mutation frequency since the beginning of the pandemic, are in line with worldwide data. Besides, some variants of concern (VOC) and variants of interest (VOI) such as Gamma, Mu and Lambda, and at least 83 other lineages have predominated locally with a country-specific enrichments. This work has contributed to the understanding of the dynamics of the pandemic in Latin America as part of the local and international efforts to achieve timely genomic surveillance of SARS-CoV-2.


Subject(s)
COVID-19
2.
Carolina Torres; Laura Mojsiejczuk; Dolores Acuna; Sofia Alexay; Ariel Amadio; Paula Aulicino; Humberto Debat; Franco Fernandez; Stephanie Goya; Guido Konig; Mercedes Nabaes Jodar; Luis Pianciola; Sofia Bengoa; Marco Cacciahue; Cecilia Camussone; Maria Jose Dus Santos; Maria Florencia Eberhardt; Ailen Fernandez; Maria Ines Gismondi; Matias Irazoqui; Silvina Lusso; Nathalie Marquez; Marianne Munoz; Monica Natale; Belen Pisano; Andrea Puebla; Viviana Re; Ezequiel Sosa; Jonathan Zaiat; Sebastian Zunino; Dario Do porto; Maria Elina Acevedo; Cristina Alvarez Lopez; Maria Laura Alvarez; Patricia Angeleri; Andres Angelletti; Manuel Arca; Gabriela Barbas; Ana Bertone; Agustina Bonnet; Ignacio Bourlot; Alejandro Castello; Gonzalo Castro; Carolina Ceriani; Carlos Cimino; Julian Cipelli; Maria Colmeiro; Andres Cordero; Carolina Cristina; Sofia Di Bella; Regina Ercole; Yesica Espasandin; Carlos Espul; Andrea Falaschi; Facundo Fernandez Moll; Andrea Gatelli; Sandra Goni; Maria E Jofre; Jose Jaramillo; Natalia Labarta; Maria A Lacaze; Rocio Larreche; Viviana Leiva; Gustavo Levin; Erica Luczak; Marcelo Mandile; Carla Massone; Melina Mazzeo; Carla Medina; Belen Monaco; Luciana Montoto; Viviana Mugna; Alejandra Musto; Guillermo Ojeda; Carolina Pintos; Marcia Pozzati; Marilina Rahhal; Claudia Rechimont; Federico Remes Lenicov; Gabriela Rompato; Vanesa Seery; Leticia Siri; Julieta Spina; Cintia Streitenberger; Ariel Suarez; Jorgelina Suarez; Paula Sujanski; Juan M Talia; Clara Theaux; Guillermo Thomas; Marina Ticeira; Estefania Tittarelli; Rosana Toro; Osvaldo Uez; Maria B Zaffanella; Cecilia Ziehm; Martin Zubieta; - PAIS Consortium; Alicia Mistchenko; Laura Valinotto; Mariana Viegas.
medrxiv; 2021.
Preprint in English | medRxiv | ID: ppzbmed-10.1101.2021.07.19.21260779

ABSTRACT

Molecular surveillance of SARS-CoV-2 variants was performed on a total of 2,406 samples from the capital city and nine provinces of Argentina, during 30 epidemiological weeks (EW) that covered the end of the first wave and the beginning of the ongoing second wave of the COVID-19 pandemic in the country (EW 44/2020 to EW 20/2021). The surveillance strategy was mainly based on Sanger sequencing of a Spike coding region that allows the simultaneous identification of signature mutations associated with worldwide circulating variants. In addition, whole SARS-CoV-2 genome sequences were obtained from 456 samples. The main variants found were Gamma, Lambda and Alpha, and to a lesser extent, Zeta and Epsilon. Whereas Gamma dominated in different regions of the country, both Gamma and Lambda prevailed in the most populated area, the metropolitan region of Buenos Aires (MABA), although showing a heterogeneous distribution along this region. This cost-effective surveillance protocol allowed for a rapid response in a limited access to resources scenario, added information on the expansion of the Lambda variant in South America and contributed to the implementation of public health measures to control the disease spread in Argentina.


Subject(s)
COVID-19
SELECTION OF CITATIONS
SEARCH DETAIL